Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
The course of nephrotic syndrome during levamisole treatment
| Corticosteroid dose on initiation of levamisole treatment (mg/kg/24 h) | 1.2 ±0.6 (0.1-2.0) |
| Duration of levamisole treatment (months) | 15.0 ±7.3 (6.0-31.0) |
| Duration of corticosteroid treatment during levamisole therapy (months) | 8.7 ±8.5 (1.0-31.0) |
| Time to relapse on levamisole treatment (months) | 8.8 ±8.1 (0.5-37.0) |
| Number of relapses on levamisole treatment (n); (n/year) | 1.9 ±2.1 (0-9) 1.8 ±2.1 (0.0-8.0) |
